Federal Health Grants

The National Cancer Institute (NCI) intends to publish a Notice of Funding Opportunity (NOFO), theNCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research (K12). The NOFO will invite applications for institutional research career development programs to support the training of clinical scientists in community cancer prevention, intervention, and treatment research. Special emphasis is placed on training of clinical scientists whose career goal is to meet the needs of underserved or underrepresent ed communities for access to clinical care and participation in clinical research. The NOFO will allow the appointment ofScholars proposing to serve as the lead investigator of an independent community-based clinical trial; or proposing a separate ancillary study to an existing prevention, screening or control clinical trial; or proposing to gain research experience in a community-based clinical trial led by another investigator; or proposing to serve as leader of innovative clinical trial approaches that expand engagement of underserved or underrepresented communitiesin cancer clinical research, as part of their research and career development. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive applications. The NOFO is expected to be published in April 2024 with an expected application due date in June 2024. TheNOFO will utilize theK12 activity code for Clinical Scientist Institutional Career Development Program Awards. Details of the planned NOFO are provided below.

This funding opportunity is designed to strengthen health informatics capabilities in PEPFAR-supported countries by developing a skilled workforce and enhancing digital health systems to combat HIV/AIDS and tuberculosis effectively.

This funding opportunity supports higher education institutions, nonprofit organizations, for-profit organizations, and local governments in establishing a Coordinating Center to implement and evaluate population genomic screening in primary care, focusing on diverse communities and actionable genetic conditions.

The USAID integrated Delivery of Tuberculosis Service (iDOTS) Activity grant is a funding opportunity offered by USAID/Nigeria for local organizations in Nigeria to implement tuberculosis services, with the selection process involving a three-phase process of concept submission, oral presentation, and full application submission.

This funding opportunity is designed for U.S. academic institutions with specialized mining programs to develop innovative technologies and research that improve the safety and effectiveness of underground mine evacuations during emergencies.

The United States Agency for International Development in Southern Africa (USAID/SouthernAfrica) is seeking Concept Papers from qualified entities to implement an activity entitledHealth Financing and Public Financial Management Systems Strengthening Activity in SouthAfrica. Eligibility for this award is not restricted. The authority for the Notice of FundingOpportunity (NOFO) is found in the Foreign Assistance Act of 1961, as amended.Subject to funding availability and at the discretion of the Agency, USAID intends to provide upto $30 million in total USAID funding over a five (5) year period through a CooperativeAgreement with the selected applicant. Eligible organizations interested in submitting a ConceptPaper are encouraged to read this NOFO thoroughly to understand the type of project sought(Section A), the application submission requirements (Sections C and D), and the evaluationprocess and merit review criteria (Section E). To be eligible for award, the applicant mustprovide all information required in this NOFO and meet eligibility standards in Section C.Concepts must be received by the date and time indicated at the top of this cover letter. Notethat USAID is not accepting full applications at this time - only Concept Papers.

This funding opportunity supports U.S. institutions conducting clinical trials on innovative regenerative medicine therapies using adult stem cells, focusing on extending research from previously funded projects.

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) intend to publish a Notice of Funding Opportunity (NOFO) to solicit applications for large single or multisite clinical trials within the mission area of the institute. The NOFO is expected to be published in Spring 2024 with an expected application due date in Summer 2024. Only New, Resubmission and Revision applications will be eligible. This NOFO will utilize the UG3/UH3 phased cooperative agreement activity code. A UG3 milestone plan is required. Details of the planned NOFO are provided below.

The "RFI: USAID/Washington Digital Health, Information Systems, and Data Use Request for Information" grant is a request for information from interested parties about anticipated activities in digital health, information systems, and data use, but it does not guarantee a grant, contract, or cooperative agreement award from the U.S. Government.

This funding opportunity supports Kuwait-based non-profits, educational institutions, and individuals in creating cultural and educational programs that strengthen ties between the U.S. and Kuwait, with a focus on diversity, inclusion, and shared challenges.

This Funding Opportunity Announcement (FOA) invites applications to enhance the pool of of highly trained investigators from diverse backgrounds , including those from groups underrepresented in research areas of interest to the NHLBI. The career development will take place under the guidance of an experienced mentor in the biomedical, behavioral or clinical sciences leading to research independence. It is targeted toward individuals whose basic, clinical, and translational research interests are grounded in the advanced methods and experimental approaches needed to solve problems related to cardiovascular, pulmonary, and hematologic diseases and sleep disorders in the general and health disparities populations. This FOA invites applications from Institutions with eligible faculty members to undertake special study and supervised research under a mentor who is an accomplished investigator in the research area proposed and has experience in developing independent investigators. This FOA is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or a separate ancillary clinical trial, as part of their research and career development. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor. Applicants proposing a clinical trial or an ancillary clinical trial as lead investigator, should apply to the companion FOA (see RFA-HL-22-010).

This funding opportunity supports research projects that develop and implement community-focused interventions to improve vision health outcomes and address disparities among underserved populations.

This funding opportunity is designed to support organizations that enhance Nigeria's ability to prevent, detect, and respond to infectious diseases through improved health security coordination and capacity building.

This funding opportunity provides financial support to state and local governments and organizations for planning integrated care programs that address the needs of Medicaid-eligible individuals with chronic conditions.

The grant titled "Mechanistic Investigations into ADRD Associated Protein Structures in Biological Settings" aims to use recent advancements in structural biology to study protein assemblies related to Alzheimer's disease and related dementias (AD/ADRD) in their natural environments within cells and tissues, with the goal of developing ligands that can identify and monitor these proteins in patients.

This funding opportunity supports the development of innovative computational tools to enhance the use of the human pangenome in genomic research, particularly for applications in cancer, aging, and diverse populations.

The purpose of this Funding Opportunity Announcement (FOA) is to diversify the translational research workforce for Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). This initiative will emphasize the development of skills in data science and drug discovery, and their application to various aspects of AD/ADRD research (from populations studies to research that can lead to new treatments and diagnostics, including all aspects of behavioral and social research). This initiative will support early career, independent investigators from diverse backgrounds to gain critical translational skills in data science and drug discovery. The long-term goal of this program is to develop a diverse translational workforce that can effectively participate in and/or lead a team-science, precision medicine approach to AD/ADRD treatment, prevention, early detection, and disease management and care.

This grant provides funding for research projects that implement screening and intervention strategies for alcohol, tobacco, and drug use among adult populations facing health disparities, such as racial minorities and low-income communities.

This funding opportunity supports researchers developing innovative technologies to enhance the delivery of treatments for HIV and substance use disorders, focusing on improving patient outcomes and understanding the effects of addictive substances.

This funding opportunity provides small grants to early-career researchers who have received specific NHLBI K awards, allowing them to expand their research projects or explore new studies that build on their previous work.